Low-dose aspirin and COX inhibition in human skeletal muscle.
aerobic exercise
cyclooxygenase
low-dose aspirin
prostaglandin E2
skeletal muscle
Journal
Journal of applied physiology (Bethesda, Md. : 1985)
ISSN: 1522-1601
Titre abrégé: J Appl Physiol (1985)
Pays: United States
ID NLM: 8502536
Informations de publication
Date de publication:
01 12 2020
01 12 2020
Historique:
pubmed:
2
10
2020
medline:
24
6
2021
entrez:
1
10
2020
Statut:
ppublish
Résumé
Skeletal muscle health has been shown to benefit from regular consumption of cyclooxygenase (COX)-inhibiting drugs. Aspirin, especially at low doses, is one of the most commonly consumed COX inhibitors, yet investigations of low-dose aspirin effects on skeletal muscle are nonexistent. The goal of this study was to examine the efficacy of low-dose aspirin on skeletal muscle COX production of the inflammatory regulator prostaglandin (PG)E
Identifiants
pubmed: 33002382
doi: 10.1152/japplphysiol.00512.2020
doi:
Substances chimiques
Cyclooxygenase Inhibitors
0
Cyclooxygenase 2
EC 1.14.99.1
Aspirin
R16CO5Y76E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM